Intraocular Lens (IOL) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Intraocular Lens (IOL) Pipeline Market Report Overview

Intraocular lens is an artificial lens made of plastic, silicone, acrylic or other material that is implanted inside the eye during cataract surgery. Foldable (phakic) IOL and Polymethyl Methacrylate (PMMA) IOL are tracked under this category.

The Intraocular Lens (IOL) pipeline market research report provides comprehensive information about the IOL pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Key Segments ·       Polymethyl Methacrylate (PMMA) IOL

·       Foldable IOL

·       Monofocal Foldable IOL

·       Multifocal Foldable IOL

Key Territories ·       The US

·       Europe

·       China

·       Japan

·       India

·       Canada

·       Australia

·       New Zealand

·       Singapore

·       Israel

Key Regulatory Paths ·       PMA

·       CE

·       NMPA

·       Shonin

·       ICAC

·       MDL

·       HDE Approvals

·       HAS

·       TGA

·       510(k)

Leading Companies ·       Adaptilens LLC

·       Adoptics AG (Inactive)

·       AkkoLens International BV

·       Alcon Inc

·       Anew Optics, Inc.

·       Atia Vision Inc

·       Bausch & Lomb Inc

·       Care Group

·       CEYEBER Corp

·       Clarvista Medical Inc

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

IOL Pipeline Market by Segments

The key segments in the IOL market are Polymethyl Methacrylate (PMMA) IOL, Foldable IOL, Monofocal Foldable IOL, and Multifocal Foldable IOL. As of July 2023, Polymethyl Methacrylate (PMMA) IOL has the highest number of pipeline products. Such IOLs remain a preferred choice for people with a history of uveitis, diabetic retinopathy requiring vitrectomy, or at high risk of retinal detachment.

IOL Pipeline Market Analysis by Segments, 2023 (%)

IOL Pipeline Market Analysis by Segments, 2023 (%)

For more segment insights into the IOL pipeline market, download a free report sample

IOL Pipeline Market Segmentation by Territories

Some of the key territories in the IOL market are the US, Europe, China, Japan, India, Canada, Australia, New Zealand, Singapore, and Israel. As of July 2023, the US has the highest number of pipeline products.

IOL Pipeline Market Analysis by Territories, 2023 (%)

IOL Pipeline Market Analysis by Territories, 2023 (%)

For more territory insights into the IOL pipeline market, download a free report sample

IOL Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the IOL pipeline market are PMA, CE, NMPA, Shonin, ICAC, MDL, HDE Approvals, HSA, TGA, and 510(k). As of July 2023, PMA is the most followed pathway for pipeline products in the market.

IOL Pipeline Market Analysis by Regulatory Paths, 2023 (%)

IOL Pipeline Market Analysis by Regulatory Paths, 2023 (%)

For more regulatory path insights into the IOL pipeline market, download a free report sample

IOL Pipeline Market – Competitive Landscape

Some of the key companies in the IOL pipeline market are Adaptilens LLC, Adoptics AG (Inactive), AkkoLens International BV, Alcon Inc, Anew Optics, Inc., Atia Vision Inc, Bausch & Lomb Inc, Care Group, CEYEBER Corp, and Clarvista Medical Inc.

AkkoLens International BV: The medical device company provides products such as intraocular lenses and ophthalmological surgery equipment. It offers clinical trials, registration, and sales and investment services. AkkoLens’ products are used for therapeutic areas of cataract and reading-far-sightedness. The company is headquartered in Breda, the Netherlands.

Alcon Inc: The company is engaged in the development and manufacturing of devices in the field of ophthalmology. The company’s portfolio encompasses contact lenses and surgical products, including implantables, consumables, and surgical equipment. The company’s products are indicated for the treatment of various conditions such as cataracts, glaucoma, retinal diseases, and refractive errors. Alcon is headquartered in Geneva, Switzerland.

Leading Intraocular Lens (IOL) Companies, 2023

Leading Intraocular Lens (IOL) Companies, 2023

For more company insights into the IOL pipeline market, download a free report sample

Segments Covered in the Report

IOL Pipeline Market Segments Outlook

  • Polymethyl Methacrylate (PMMA) IOL
  • Foldable IOL
  • Monofocal Foldable IOL
  • Multifocal Foldable IOL

IOL Pipeline Market Territories Outlook

  • The US
  • Europe
  • China
  • Japan
  • India
  • Canada
  • Australia
  • New Zealand
  • Singapore
  • Israel

IOL Pipeline Market Regulatory Paths Outlook

  • PMA
  • CE
  • NMPA
  • Shonin
  • ICAC
  • MDL
  • HDE Approvals
  • HAS
  • TGA
  • 510(k)

Scope

This report provides:

  • Extensive coverage of the Intraocular Lens (IOL) under development.
  • Details of major pipeline products which includes product description, licensing and collaboration details, and other developmental activities.
  • Reviews of the major players involved in the development of Intraocular Lens (IOL) and lists of all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage
  • Identify and understand important and diverse types of IOL under development
  • Develop market-entry and market-expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

Adaptilens LLC
Adoptics AG (Inactive)
AkkoLens International BV
Alcon Inc
Anew Optics, Inc.
Atia Vision Inc
Bausch & Lomb Inc
Care Group
CEYEBER Corp
Clarvista Medical Inc
ClearSight LLC
Cord LLC
Elenza, Inc.
Emmetrope Incorporated
EyeKon Medical Inc
ForSight Vision6 Inc
Gaush Meditech Ltd
Henan Universe Intraocular Lens Development Co Ltd
Hoya Surgical Optics Inc
Innovia LLC
Johnson & Johnson Surgical Vision Inc
LensGen Inc
London Eye Hospital
Medicontur Medical Engineering Ltd
Meir Medical Center
Morcher Gmbh
Nayam Innovations Pvt Ltd
Nidek Co Ltd
Northwestern University
NuLens Ltd. (Inactive)
Ocumetics Technology Corp
PhysIOL SA
PowerVision Inc
Presbeasy
Rayner Intraocular Lenses Ltd
Sav-Iol SA
Shanghai Haohai Biological Technology Co Ltd
STAAR Surgical Company
Strathspey Crown LLC
Tianjin Century Kangtai Biomedical Engineering Co Ltd
Ulsan National Institute of Science and Technology
University of East Anglia
University of Rochester
University of Tampere
VA St. Louis Health Care System
Visidome Ltd
Visioneering Technologies Inc
VisusNano Labs
Voptica SL
VSY Biotechnology BV
Washington University in St Louis
Xend
Xi'an Eyedele Medical Technology Co Ltd
Z Lens LLC

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 6

|1.2 List of Figures 12

2 Introduction 13

2.1 Intraocular Lens (IOL) Overview 13

3 Products under Development 14

3.1 Intraocular Lens (IOL) – Pipeline Products by Stage of Development 14

3.2 Intraocular Lens (IOL) – Pipeline Products by Segment 15

3.3 Intraocular Lens (IOL) – Pipeline Products by Territory 16

3.4 Intraocular Lens (IOL) – Pipeline Products by Regulatory Path 17

3.5 Intraocular Lens (IOL) – Pipeline Products by Estimated Approval Date 18

3.6 Intraocular Lens (IOL) – Ongoing Clinical Trials 19

4 Intraocular Lens (IOL) – Pipeline Products under Development by Companies 20

4.1 Intraocular Lens (IOL) Companies – Pipeline Products by Stage of Development 20

4.2 Intraocular Lens (IOL) – Pipeline Products by Stage of Development 23

5 Intraocular Lens (IOL) Companies and Product Overview 26

5.1 Adaptilens LLC Company Overview 26

5.1.1 Adaptilens LLC Pipeline Products & Ongoing Clinical Trials Overview 26

5.2 Adoptics AG (Inactive) Company Overview 27

5.2.1 Adoptics AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 27

5.3 AkkoLens International BV Company Overview 28

5.3.1 AkkoLens International BV Pipeline Products & Ongoing Clinical Trials Overview 28

5.4 Alcon Inc Company Overview 29

5.4.1 Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview 29

5.5 Anew Optics, Inc. Company Overview 34

5.5.1 Anew Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34

5.6 Atia Vision Inc Company Overview 35

5.6.1 Atia Vision Inc Pipeline Products & Ongoing Clinical Trials Overview 35

5.7 Bausch & Lomb Inc Company Overview 38

5.7.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 38

5.8 Care Group Company Overview 45

5.8.1 Care Group Pipeline Products & Ongoing Clinical Trials Overview 45

5.9 CEYEBER Corp Company Overview 49

5.9.1 CEYEBER Corp Pipeline Products & Ongoing Clinical Trials Overview 49

5.10 Clarvista Medical Inc Company Overview 50

5.10.1 Clarvista Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 50

5.11 ClearSight LLC Company Overview 51

5.11.1 ClearSight LLC Pipeline Products & Ongoing Clinical Trials Overview 51

5.12 Cord LLC Company Overview 52

5.12.1 Cord LLC Pipeline Products & Ongoing Clinical Trials Overview 52

5.13 Elenza, Inc. Company Overview 55

5.13.1 Elenza, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55

5.14 Emmetrope Incorporated Company Overview 56

5.14.1 Emmetrope Incorporated Pipeline Products & Ongoing Clinical Trials Overview 56

5.15 EyeKon Medical Inc Company Overview 59

5.15.1 EyeKon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 59

5.16 ForSight Vision6 Inc Company Overview 60

5.16.1 ForSight Vision6 Inc Pipeline Products & Ongoing Clinical Trials Overview 60

5.17 Gaush Meditech Ltd Company Overview 61

5.17.1 Gaush Meditech Ltd Pipeline Products & Ongoing Clinical Trials Overview 61

5.18 Henan Universe Intraocular Lens Development Co Ltd Company Overview 64

5.18.1 Henan Universe Intraocular Lens Development Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 64

5.19 Hoya Surgical Optics Inc Company Overview 67

5.19.1 Hoya Surgical Optics Inc Pipeline Products & Ongoing Clinical Trials Overview 67

5.20 Innovia LLC Company Overview 68

5.20.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 68

5.21 Johnson & Johnson Surgical Vision Inc Company Overview 69

5.21.1 Johnson & Johnson Surgical Vision Inc Pipeline Products & Ongoing Clinical Trials Overview 69

5.22 LensGen Inc Company Overview 74

5.22.1 LensGen Inc Pipeline Products & Ongoing Clinical Trials Overview 74

5.23 London Eye Hospital Company Overview 77

5.23.1 London Eye Hospital Pipeline Products & Ongoing Clinical Trials Overview 77

5.24 Medicontur Medical Engineering Ltd Company Overview 78

5.24.1 Medicontur Medical Engineering Ltd Pipeline Products & Ongoing Clinical Trials Overview 78

5.25 Meir Medical Center Company Overview 80

5.25.1 Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview 80

5.26 Morcher Gmbh Company Overview 81

5.26.1 Morcher Gmbh Pipeline Products & Ongoing Clinical Trials Overview 81

5.27 Nayam Innovations Pvt Ltd Company Overview 93

5.27.1 Nayam Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 93

5.28 Nidek Co Ltd Company Overview 95

5.28.1 Nidek Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 95

5.29 Northwestern University Company Overview 96

5.29.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 96

5.30 NuLens Ltd. (Inactive) Company Overview 97

5.30.1 NuLens Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 97

5.31 Ocumetics Technology Corp Company Overview 98

5.31.1 Ocumetics Technology Corp Pipeline Products & Ongoing Clinical Trials Overview 98

5.32 PhysIOL SA Company Overview 99

5.32.1 PhysIOL SA Pipeline Products & Ongoing Clinical Trials Overview 99

5.33 PowerVision Inc Company Overview 100

5.33.1 PowerVision Inc Pipeline Products & Ongoing Clinical Trials Overview 100

5.34 Presbeasy Company Overview 103

5.34.1 Presbeasy Pipeline Products & Ongoing Clinical Trials Overview 103

5.35 Rayner Intraocular Lenses Ltd Company Overview 104

5.35.1 Rayner Intraocular Lenses Ltd Pipeline Products & Ongoing Clinical Trials Overview 104

5.36 Sav-Iol SA Company Overview 110

5.36.1 Sav-Iol SA Pipeline Products & Ongoing Clinical Trials Overview 110

5.37 Shanghai Haohai Biological Technology Co Ltd Company Overview 111

5.37.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 111

5.38 STAAR Surgical Company Company Overview 114

5.38.1 STAAR Surgical Company Pipeline Products & Ongoing Clinical Trials Overview 114

5.39 Strathspey Crown LLC Company Overview 118

5.39.1 Strathspey Crown LLC Pipeline Products & Ongoing Clinical Trials Overview 118

5.40 Tianjin Century Kangtai Biomedical Engineering Co Ltd Company Overview 119

5.40.1 Tianjin Century Kangtai Biomedical Engineering Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 119

5.41 Ulsan National Institute of Science and Technology Company Overview 120

5.41.1 Ulsan National Institute of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 120

5.42 University of East Anglia Company Overview 121

5.42.1 University of East Anglia Pipeline Products & Ongoing Clinical Trials Overview 121

5.43 University of Rochester Company Overview 122

5.43.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 122

5.44 University of Tampere Company Overview 123

5.44.1 University of Tampere Pipeline Products & Ongoing Clinical Trials Overview 123

5.45 VA St. Louis Health Care System Company Overview 124

5.45.1 VA St. Louis Health Care System Pipeline Products & Ongoing Clinical Trials Overview 124

5.46 Visidome Ltd Company Overview 125

5.46.1 Visidome Ltd Pipeline Products & Ongoing Clinical Trials Overview 125

5.47 Visioneering Technologies Inc Company Overview 126

5.47.1 Visioneering Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 126

5.48 VisusNano Labs Company Overview 127

5.48.1 VisusNano Labs Pipeline Products & Ongoing Clinical Trials Overview 127

5.49 Voptica SL Company Overview 128

5.49.1 Voptica SL Pipeline Products & Ongoing Clinical Trials Overview 128

5.50 VSY Biotechnology BV Company Overview 129

5.50.1 VSY Biotechnology BV Pipeline Products & Ongoing Clinical Trials Overview 129

5.51 Washington University in St Louis Company Overview 130

5.51.1 Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview 130

5.52 Xend Company Overview 131

5.52.1 Xend Pipeline Products & Ongoing Clinical Trials Overview 131

5.53 Xi’an Eyedele Medical Technology Co Ltd Company Overview 132

5.53.1 Xi’an Eyedele Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 132

5.54 Z Lens LLC Company Overview 133

5.54.1 Z Lens LLC Pipeline Products & Ongoing Clinical Trials Overview 133

6 Intraocular Lens (IOL)- Recent Developments 134

6.1 May 08, 2023: Hoya announces consolidated financial results for the fiscal year ended March 31, 2023 134

6.2 May 03, 2023: Smartlens, announces positive clinical results for miLens, a novel, soft contact lens for monitoring intraocular pressure 134

6.3 Mar 29, 2023: STAAR Surgical Names Warren Foust Chief Operating Officer; Magda Michna, Ph.D., Chief Clinical, Regulatory and Medical Affairs Officer 134

6.4 Feb 10, 2023: Carl Zeiss Meditec achieves further revenue growth in First quarter 2022/23 135

6.5 Feb 02, 2023: NIDEK and HOYA Vision Care Enter Global Partnership 136

6.6 Jan 31, 2023: Hoya Announces Fourth semi-annual financial statements 137

6.7 Jan 23, 2023: Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2022 Financial Results on February 22 139

6.8 Jan 23, 2023: UT Southwestern ophthalmologist shares techniques for cataract surgery complications 139

6.9 Jan 09, 2023: STAAR Surgical Reports Preliminary Sales for Fourth Quarter and Fiscal 2022 140

6.10 Jan 08, 2023: RxSight Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial and Operational Results 141

6.11 Oct 04, 2022: Bausch + Lomb Will Release Third-Quarter 2022 Financial Results on November 2 142

6.12 Sep 28, 2022: Bausch Health Announces Final Results and Expiration of Exchange Offers and Consent Solicitations 142

6.13 Sep 26, 2022: Bausch & Lomb Will Present New Scientific Data and Analyses During the American Academy of Ophthalmology Annual Meeting 143

6.14 Sep 12, 2022: Santen Announces Change of Representative Director of the Board (change in CEO) 144

6.15 Aug 30, 2022: Rayner announces ESCRS 2022 programme with a pledge to reduce carbon footprint 145

6.16 Aug 10, 2022: STAAR Surgical Reports Record Second Quarter Net Sales of $81.1 Million Up 30% Y/Y 146

6.17 Jul 27, 2022: Bausch Health Companies will Release Second-Quarter 2022 Financial Results on Aug. 9 148

6.18 Jul 20, 2022: Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance 149

6.19 Jul 18, 2022: Carl Zeiss Meditec and Precise Bio announce partnership in the development and commercialization of tissue-based implants for ophthalmology 150

6.20 Jul 11, 2022: Rayner Continues European Growth With Direct Presence In France 150

7 Appendix 152

7.1 Methodology 152

7.2 About GlobalData 155

7.3 Contact Us 155

7.4 Disclaimer 155

Table

Intraocular Lens (IOL) – Pipeline Products by Stage of Development 14

Intraocular Lens (IOL) – Pipeline Products by Segment 15

Intraocular Lens (IOL) – Pipeline Products by Territory 16

Intraocular Lens (IOL) – Pipeline Products by Regulatory Path 17

Intraocular Lens (IOL) – Pipeline Products by Estimated Approval Date 18

Intraocular Lens (IOL) – Ongoing Clinical Trials 19

Intraocular Lens (IOL) Companies – Pipeline Products by Stage of Development 20

Intraocular Lens (IOL) – Pipeline Products by Stage of Development 23

Adaptilens LLC Pipeline Products & Ongoing Clinical Trials Overview 26

Adaptilens – Product Status 26

Adaptilens – Product Description 26

Adoptics AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 27

Shape-Changing Accommodating Intraocular Lens – Product Status 27

Shape-Changing Accommodating Intraocular Lens – Product Description 27

AkkoLens International BV Pipeline Products & Ongoing Clinical Trials Overview 28

AkkoLens IOL – Product Status 28

AkkoLens IOL – Product Description 28

Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview 29

AcrySof IQ ReSTOR 3.0D Toric IOL Diopter Range Expansion – Product Status 29

AcrySof IQ ReSTOR 3.0D Toric IOL Diopter Range Expansion – Product Description 30

AcrySof IQ ReSTOR Distant Dominant 2.5D – Product Status 30

AcrySof IQ ReSTOR Distant Dominant 2.5D – Product Description 30

AcrySof IQ ReSTOR Toric IOL Diopter Range Expansion – Product Status 30

AcrySof IQ ReSTOR Toric IOL Diopter Range Expansion – Product Description 31

AcrySof IQ Toric Diopter Range Expansion – Product Status 31

AcrySof IQ Toric Diopter Range Expansion – Product Description 31

AcrySof IQ Toric IOL Low Diopter Range Expansion – Product Status 32

AcrySof IQ Toric IOL Low Diopter Range Expansion – Product Description 32

Intrepid IOL – Product Status 32

Intrepid IOL – Product Description 33

Anew Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34

Zephyr Lens – Product Status 34

Zephyr Lens – Product Description 34

Atia Vision Inc Pipeline Products & Ongoing Clinical Trials Overview 35

OmniVu IOL System – Product Status 35

OmniVu IOL System – Product Description 35

Atia Vision Inc – Ongoing Clinical Trials Overview 36

OmniVu IOL System – A Prospective, Open-label, Single-center Study of the Atia AVL200 Modular Intraocular Lens System for Treatment of Cataract and Presbyopia 37

Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 38

enVista Aspire – Product Status 38

enVista Aspire – Product Description 38

enVista Dynamic – Product Status 39

enVista Dynamic – Product Description 39

enVista Envy – Product Status 39

enVista Envy – Product Description 39

enVista MX60EF Trifocal IOL – Product Status 40

enVista MX60EF Trifocal IOL – Product Description 40

Extended Depth Of Focus Intraocular Lens – Product Status 40

Extended Depth Of Focus Intraocular Lens – Product Description 41

LuxLife (Trifocal) – Product Status 41

LuxLife (Trifocal) – Product Description 41

LuxSmart – Toric Version – Product Status 41

LuxSmart – Toric Version – Product Description 42

Sarfarazi Elliptical Accommodating IOL – Product Status 42

Sarfarazi Elliptical Accommodating IOL – Product Description 42

Bausch & Lomb Inc – Ongoing Clinical Trials Overview 43

enVista MX60EF Trifocal IOL – A Prospective, Multicenter, Randomized, Active-controlled Clinical Study to Evaluate the Safety and Effectiveness of the enVista One-piece Hydrophobic Acrylic Trifocal Intraocular Lens in Subjects Undergoing Cataract Extraction 44

Care Group Pipeline Products & Ongoing Clinical Trials Overview 45

Hydrophilic Diffractive IOL – Product Status 45

Hydrophilic Diffractive IOL – Product Description 45

Hydrophobic IOL (MICL) – Product Status 46

Hydrophobic IOL (MICL) – Product Description 46

IPCL Monofocal – Product Status 46

IPCL Monofocal – Product Description 47

Prism IOL – Product Status 47

Prism IOL – Product Description 47

Scleral Fixation IOL – Product Status 48

Scleral Fixation IOL – Product Description 48

X-Centric IOL – Product Status 48

X-Centric IOL – Product Description 48

CEYEBER Corp Pipeline Products & Ongoing Clinical Trials Overview 49

Third Eye – Product Status 49

Third Eye – Product Description 49

Clarvista Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 50

Second Generation HARMONI System – Product Status 50

Second Generation HARMONI System – Product Description 50

ClearSight LLC Pipeline Products & Ongoing Clinical Trials Overview 51

ClearSight IOL – Product Status 51

ClearSight IOL – Product Description 51

Cord LLC Pipeline Products & Ongoing Clinical Trials Overview 52

Model SC9 Lens – Product Status 52

Model SC9 Lens – Product Description 52

Cord LLC – Ongoing Clinical Trials Overview 53

Model SC9 Lens – A Clinical Trial to Evaluate the Safety and Effectiveness of Model SC9 Silicone IOL for the Visual Correction of Aphakia Secondary to the Removal of a Cataractous Lens in Adult Patients with or without Presbyopia 54

Elenza, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55

Sapphire Autofocal IOL – Product Status 55

Sapphire Autofocal IOL – Product Description 55

Emmetrope Incorporated Pipeline Products & Ongoing Clinical Trials Overview 56

ActaLens – Product Status 56

ActaLens – Product Description 56

ActaLens-Duo – Product Status 57

ActaLens-Duo – Product Description 57

ActaLens-SC – Product Status 57

ActaLens-SC – Product Description 58

EyeKon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 59

AQ204 Natural Clear IOL – Product Status 59

AQ204 Natural Clear IOL – Product Description 59

ForSight Vision6 Inc Pipeline Products & Ongoing Clinical Trials Overview 60

Intraocular Lens – Product Status 60

Intraocular Lens – Product Description 60

Gaush Meditech Ltd Pipeline Products & Ongoing Clinical Trials Overview 61

ACUNEX Quantum – Product Status 61

ACUNEX Quantum – Product Description 61

ACUNEX Quantum Toric – Product Status 62

ACUNEX Quantum Toric – Product Description 62

FEMTIS Quantum – Product Status 62

FEMTIS Quantum – Product Description 63

LENTIS Quantum Toric – Product Status 63

LENTIS Quantum Toric – Product Description 63

Henan Universe Intraocular Lens Development Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 64

PMEA60 Multifocal Intraocular Lens – Product Status 64

PMEA60 Multifocal Intraocular Lens – Product Description 64

Henan Universe Intraocular Lens Development Co Ltd – Ongoing Clinical Trials Overview 65

PMEA60 Multifocal Intraocular Lens – Multicenter Clinical Trial to Evaluate the Efficacy and Safety of Multifocal Intraocular Lens (PMEA60) 66

Hoya Surgical Optics Inc Pipeline Products & Ongoing Clinical Trials Overview 67

Artificial Crystalline Lens – Product Status 67

Artificial Crystalline Lens – Product Description 67

Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 68

Accommodating Intraocular Lens – Product Status 68

Accommodating Intraocular Lens – Product Description 68

Johnson & Johnson Surgical Vision Inc Pipeline Products & Ongoing Clinical Trials Overview 69

IOL Model C0002 – Product Status 69

IOL Model C0002 – Product Description 69

TECNIS IOL Model C1V000 – Product Status 70

TECNIS IOL Model C1V000 – Product Description 70

TECNIS IOL Model C2V000 – Product Status 70

TECNIS IOL Model C2V000 – Product Description 71

Johnson & Johnson Surgical Vision Inc – Ongoing Clinical Trials Overview 72

IOL Model C0002 – Proof-of-concept Study for New Intraocular Lens, Model C0002 73

LensGen Inc Pipeline Products & Ongoing Clinical Trials Overview 74

Juvene – Product Status 74

Juvene – Product Description 74

LensGen Inc – Ongoing Clinical Trials Overview 75

Juvene – A Prospective, Randomized, Controlled, Double-Masked, Phased, Multi-center Clinical Study to Evaluate the Safety and Efficacy of the LensGen Juvene Intraocular Lens 76

London Eye Hospital Pipeline Products & Ongoing Clinical Trials Overview 77

iolAMD – Product Status 77

iolAMD – Product Description 77

Medicontur Medical Engineering Ltd Pipeline Products & Ongoing Clinical Trials Overview 78

Hydrophobic IOL – Product Status 78

Hydrophobic IOL – Product Description 78

Progressive Varifocal IOL – Product Status 79

Progressive Varifocal IOL – Product Description 79

Toric IOL – Product Status 79

Toric IOL – Product Description 79

Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview 80

PiDO – Product Status 80

PiDO – Product Description 80

Morcher Gmbh Pipeline Products & Ongoing Clinical Trials Overview 81

Anterior Chamber IOL TYPE 54A – Product Status 81

Anterior Chamber IOL TYPE 54A – Product Description 82

Anterior Chamber IOL TYPE 54B – Product Status 82

Anterior Chamber IOL TYPE 54B – Product Description 82

Anterior Chamber IOLs TYPE 54 – Product Status 83

Anterior Chamber IOLs TYPE 54 – Product Description 83

Diplopia IOLs TYPE 85F – Product Status 83

Diplopia IOLs TYPE 85F – Product Description 84

Makula IOL TYPE 25B – Product Status 84

Makula IOL TYPE 25B – Product Description 84

Microophthalmus IOLs TYPE 27D – Product Status 85

Microophthalmus IOLs TYPE 27D – Product Description 85

Myopia IOLs TYPE 22S – Product Status 85

Myopia IOLs TYPE 22S – Product Description 86

Myopia IOLs TYPE 71A – Product Status 86

Myopia IOLs TYPE 71A – Product Description 86

Myopia IOLs TYPE 71B – Product Status 87

Myopia IOLs TYPE 71B – Product Description 87

Phakic IOLs TYPE 99A – Product Status 87

Phakic IOLs TYPE 99A – Product Description 88

Phakic IOLs TYPE 99B – Product Status 88

Phakic IOLs TYPE 99B – Product Description 88

Phakic IOLs TYPE 99C – Product Status 89

Phakic IOLs TYPE 99C – Product Description 89

Phakic IOLs TYPE 99D – Product Status 89

Phakic IOLs TYPE 99D – Product Description 90

Sclera IOLs Type 27L – Product Status 90

Sclera IOLs Type 27L – Product Description 90

Sclera IOLs Type 53S – Product Status 91

Sclera IOLs Type 53S – Product Description 91

Sclera IOLs Type 66 – Product Status 91

Sclera IOLs Type 66 – Product Description 92

Sclera IOLs Type 81B – Product Status 92

Sclera IOLs Type 81B – Product Description 92

Nayam Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 93

E-SITE – Product Status 93

E-SITE – Product Description 93

I-SITE – Product Status 94

I-SITE – Product Description 94

Nidek Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 95

Nidek Toric Intraocular Lens – Product Status 95

Nidek Toric Intraocular Lens – Product Description 95

Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 96

3D Printed Intraocular Lens – Product Status 96

3D Printed Intraocular Lens – Product Description 96

NuLens Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 97

NuLens Dynacurvature IOL – Product Status 97

NuLens Dynacurvature IOL – Product Description 97

Ocumetics Technology Corp Pipeline Products & Ongoing Clinical Trials Overview 98

Bionic Lens – Product Status 98

Bionic Lens – Product Description 98

PhysIOL SA Pipeline Products & Ongoing Clinical Trials Overview 99

FineVision HP – Product Status 99

FineVision HP – Product Description 99

PowerVision Inc Pipeline Products & Ongoing Clinical Trials Overview 100

FluidVision Lens – Product Status 100

FluidVision Lens – Product Description 100

PowerVision Inc – Ongoing Clinical Trials Overview 101

FluidVision Lens – Randomized Controlled Study of Fluid Accommodating IOL Outcomes Versus Monofocal Control 102

Presbeasy Pipeline Products & Ongoing Clinical Trials Overview 103

Presbeasy Lens – Product Status 103

Presbeasy Lens – Product Description 103

Rayner Intraocular Lenses Ltd Pipeline Products & Ongoing Clinical Trials Overview 104

Next Generation Intraocular Lens – Product Status 104

Next Generation Intraocular Lens – Product Description 104

P-flex – Product Status 105

P-flex – Product Description 105

RayOne EMV – Product Status 105

RayOne EMV – Product Description 106

RayOne Trifocal – Product Status 106

RayOne Trifocal – Product Description 106

Rayner Intraocular Lenses Ltd – Ongoing Clinical Trials Overview 107

RayOne Trifocal – Visual Function in Subjects Implanted With Advanced Technology Intraocular Lenses 108

RayOne EMV – Performance of Two Non-diffractive Intraocular Lenses with Extended Depth of Vision Set for Mini-monovision 109

RayOne EMV – RayOne EMV Mini-monovision – Efficiency and Safety of 3 Grades of Mini-monovision 109

RayOne EMV – Visual Outcomes and Patient Satisfaction After Bilateral Implantation of Non-diffractive Extended Depth of Focus (Rayone EMV Edof Iol) And Aspheric Monofocal (Rayone Aspheric Iol) Intraocular Lenses With Monovision Strategy for Near Vision Correction Among Those With Senile Cataract 109

Sav-Iol SA Pipeline Products & Ongoing Clinical Trials Overview 110

R-TASC – Product Status 110

R-TASC – Product Description 110

Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 111

Hydrophobic Molded Toric Aspheric IOL – Product Status 111

Hydrophobic Molded Toric Aspheric IOL – Product Description 111

Innovative Casting Molded Hydrophobic Aspheric IOL – Product Status 112

Innovative Casting Molded Hydrophobic Aspheric IOL – Product Description 112

Innovative Pre-loaded IOL – Product Status 112

Innovative Pre-loaded IOL – Product Description 112

Ortho K-Lens – Product Status 113

Ortho K-Lens – Product Description 113

STAAR Surgical Company Pipeline Products & Ongoing Clinical Trials Overview 114

EVO+Visian ICL – Presbyopia – Product Status 114

EVO+Visian ICL – Presbyopia – Product Description 114

STAAR Accomodating IOL – Product Status 115

STAAR Accomodating IOL – Product Description 115

Visian Implantable Collamer Lens – V5 – Product Status 115

Visian Implantable Collamer Lens – V5 – Product Description 116

Visian Implantable Collamer Lens V6a – Product Status 116

Visian Implantable Collamer Lens V6a – Product Description 116

Visian Implantable Collamer Lens V6b – Product Status 117

Visian Implantable Collamer Lens V6b – Product Description 117

Strathspey Crown LLC Pipeline Products & Ongoing Clinical Trials Overview 118

Camera-Integrated Acrylic IOLs – Product Status 118

Camera-Integrated Acrylic IOLs – Product Description 118

Tianjin Century Kangtai Biomedical Engineering Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 119

Hydrophobic Intraocular Lens – Product Status 119

Hydrophobic Intraocular Lens – Product Description 119

Ulsan National Institute of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 120

Smart Contact Lens Sensor – Product Status 120

Smart Contact Lens Sensor – Product Description 120

University of East Anglia Pipeline Products & Ongoing Clinical Trials Overview 121

Intraocular Lens – Cataract – Product Status 121

Intraocular Lens – Cataract – Product Description 121

University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 122

Multifocal Ophthalmic Lens – Product Status 122

Multifocal Ophthalmic Lens – Product Description 122

University of Tampere Pipeline Products & Ongoing Clinical Trials Overview 123

Artificial Lens – Product Status 123

Artificial Lens – Product Description 123

VA St. Louis Health Care System Pipeline Products & Ongoing Clinical Trials Overview 124

Intraocular Lens – Product Status 124

Intraocular Lens – Product Description 124

Visidome Ltd Pipeline Products & Ongoing Clinical Trials Overview 125

Accomodative IOL – Product Status 125

Accomodative IOL – Product Description 125

Visioneering Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 126

Intraocular Lens – Product Status 126

Intraocular Lens – Product Description 126

VisusNano Labs Pipeline Products & Ongoing Clinical Trials Overview 127

Drug-Eluting Intraocular Lens Implant – Product Status 127

Drug-Eluting Intraocular Lens Implant – Product Description 127

Voptica SL Pipeline Products & Ongoing Clinical Trials Overview 128

ArtIOLs – Product Status 128

ArtIOLs – Product Description 128

VSY Biotechnology BV Pipeline Products & Ongoing Clinical Trials Overview 129

Enova – Product Status 129

Enova – Product Description 129

Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview 130

Intraocular Artificial Lens – Product Status 130

Intraocular Artificial Lens – Product Description 130

Xend Pipeline Products & Ongoing Clinical Trials Overview 131

Intraocular Lens – Product Status 131

Intraocular Lens – Product Description 131

Xi’an Eyedele Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 132

Polyolefin Intraocular Lens – Product Status 132

Polyolefin Intraocular Lens – Product Description 132

Z Lens LLC Pipeline Products & Ongoing Clinical Trials Overview 133

AD-IOL System – Product Status 133

AD-IOL System – Product Description 133

Glossary 154

Figures

Intraocular Lens (IOL) – Pipeline Products by Stage of Development 14

Intraocular Lens (IOL) – Pipeline Products by Segment 15

Intraocular Lens (IOL) – Pipeline Products by Territory 16

Intraocular Lens (IOL) – Pipeline Products by Regulatory Path 17

Intraocular Lens (IOL) – Pipeline Products by Estimated Approval Date 18

Intraocular Lens (IOL) – Ongoing Clinical Trials 19

Frequently asked questions

Intraocular Lens (IOL) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Intraocular Lens (IOL) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Intraocular Lens (IOL) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Intraocular Lens (IOL) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.